What is PDS Biotechnology Corporation Annual Net Profit?

PDS Biotechnology Corporation Annual Net Profit rose 12.42% in the last year to $37.61 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is PDS Biotechnology Corporation Price to Earning Ratio?

PDS Biotechnology Corporation Price to Earning Ratio is -1.72, which is negative.

What is PDS Biotechnology Corporation Stock Price?

PDS Biotechnology Corporation Stock Price fell 59.77% and underperformed its sector by 68.63% in the past year.

What is PDS Biotechnology Corporation Quarterly Net profit?

PDS Biotechnology Corporation Quarterly Net profit rose 27.03% YoY to $7.95 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is PDS Biotechnology Corporation Debt to Equity Ratio?

PDS Biotechnology Corporation Debt to Equity Ratio of 1.15 is higher than 1. This implies that company assets are financed through debt.

What is PDS Biotechnology Corporation Return on Equity(ROE)?

PDS Biotechnology Corporation Return on Equity(ROE) for the last financial year was -166.65%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is PDS Biotechnology Corporation Mutual Fund Holding?

PDS Biotechnology Corporation Mutual Fund Holding decreased by 0.13% in the last quarter to 8.99.

What is PDS Biotechnology Corporation Promoter Share Holding?

PDS Biotechnology Corporation Promoter Share Holding increased by 0.1% in the most recent quarter to 9.13%.

What is PDS Biotechnology Corporation Interest Coverage Ratio?

PDS Biotechnology Corporation Interest Coverage Ratio is -7.23, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is PDS Biotechnology Corporation Institutional Holding?

PDS Biotechnology Corporation Institutional Holding increased by 0.14% in the last quarter to 9.5.

PDS Biotechnology Corporation XNAS: PDSB

PDS Biotechnology Corporation Live Share Price Today, Share Analysis and Chart

Name: PDS Biotechnology Corporation: Is Infosys Ltd. worth buying?
Item: PDS Biotechnology Corporation
Rating: 1.22333325
Author: Trendlyne DVM scores

about

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, pros...

1.42 0.07 (5.19%)

67.87% Fall from 52W High

523.7K XNAS Volume

High volume+gain today

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

5.3 / 100

Technically Neutral

43.6 / 100

No estimates available

PDS Biotechnology Corporation Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

PDS Biotechnology Corporation FAQ

How is PDS Biotechnology Corporation today?

PDS Biotechnology Corporation today is trading in the green, and is up by 5.19% at 1.42.

How has PDS Biotechnology Corporation performed historically?

PDS Biotechnology Corporation is currently trading up 5.19% on an intraday basis. In the past week the stock rose 18.33%. stock has been down -8.97% in the past quarter and fell -59.77% in the past year. You can view this in the overview section.